Butanedioic acid,mono[(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester cas no:3544-94-3
Synonyms: Butanedioicacid, mono[2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester,[R-(R*,R*)]-; Succinic acid, ester with chloramphenicol (6CI); Succinic acid, a-monoester withD-threo-(-)-2,2-dichloro-N-[b-hydroxy-a-(hydroxymethyl)-p-nitrophenethyl]acetamide(8CI); Acetamide, 2,2-dichloro-N-[b-hydroxy-a-(hydroxymethyl)-p-nitrophenethyl]-,a-(hydrogen succinate),D-(-)-threo- (8CI); Chloramphenicol 3-monosuccinate; Chloramphenicol acidsuccinate; Chloramphenicol hemisuccinate; Chloramphenicol hydrogen succinate;Chloramphenicol monosuccinate; Chloramphenicol succinate; Chloromycetinsuccinate; Chronicin foam; Kemicetine succinate; Levomycetin hemisuccinate;Levomycetin succinate; Paraxin succinate
NameButanedioic acid,mono[(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester
CAS3544-94-3
SynonymsButanedioicacid, mono[2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] ester,[R-(R*,R*)]-; Succinic acid, ester with chloramphenicol (6CI); Succinic acid, a-monoester withD-threo-(-)-2,2-dichloro-N-[b-hydroxy-a-(hydroxymethyl)-p-nitrophenethyl]acetamide(8CI); Acetamide, 2,2-dichloro-N-[b-hydroxy-a-(hydroxymethyl)-p-nitrophenethyl]-,a-(hydrogen succinate),D-(-)-threo- (8CI); Chloramphenicol 3-monosuccinate; Chloramphenicol acidsuccinate; Chloramphenicol hemisuccinate; Chloramphenicol hydrogen succinate;Chloramphenicol monosuccinate; Chloramphenicol succinate; Chloromycetinsuccinate; Chronicin foam; Kemicetine succinate; Levomycetin hemisuccinate;Levomycetin succinate; Paraxin succinate
EINECS(EC#)222-590-0
Molecular FormulaC15H16 Cl2 N2 O8
Molecular Weight423.23
refractive index1.589
Safety
Moderately toxic by subcutaneous, intravenous, and intraperitoneal routes. Experimental reproductive effects. When?Chloramphenicol succinate (CAS NO.3544-94-3) is heated to decomposition, it emits toxic fumes of Cl? and NOx. See also other chloramphenicol entries.
| Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
| guinea pig |
LD50 |
intravenous |
1gm/kg (1000mg/kg) |
? |
Farmaco, Edizione Scientifica. Vol. 9, Pg. 21, 1954. |
| mouse |
LD50 |
intraperitoneal |
1400mg/kg (1400mg/kg) |
? |
Farmaco, Edizione Scientifica. Vol. 9, Pg. 21, 1954. |
| mouse |
LD50 |
intravenous |
1500mg/kg (1500mg/kg) |
? |
Farmaco, Edizione Scientifica. Vol. 9, Pg. 21, 1954. |
| mouse |
LD50 |
oral |
11gm/kg (11000mg/kg) |
? |
Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 135, 1970. |
| mouse |
LD50 |
subcutaneous |
4200mg/kg (4200mg/kg) |
? |
Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 135, 1970. |
| rat |
LD50 |
intravenous |
1720mg/kg (1720mg/kg) |
? |
Therapie. Vol. 22, Pg. 1405, 1967. |
| rat |
LD50 |
oral |
8300mg/kg (8300mg/kg) |
? |
Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 135, 1970. |
| rat |
LD50 |
subcutaneous |
2400mg/kg (2400mg/kg) |
? |
Therapie. Vol. 22, Pg. 1405, 1967. |
